Literature DB >> 12805433

Identification of a single amino acid change in the human respiratory syncytial virus L protein that affects transcriptional termination.

Tara L Cartee1, A George Megaw, A G P Oomens, Gail W Wertz.   

Abstract

Infectious Human respiratory syncytial virus (HRSV) with an aberrant RNA synthesis pattern was recovered from a cDNA clone. The virus displayed increased levels of polycistronic readthrough mRNAs resulting from failure of the polymerase to terminate transcription efficiently at the gene ends. An asparagine (N) to aspartic acid (D) change at amino acid 1049 in the large (L) polymerase protein was found to be responsible for the readthrough phenotype. Virus encoding N at position 1049 displayed an RNA synthesis pattern indistinguishable from the A2 strain of HRSV. We compared the transcriptional activities of polymerases that encoded an N or D at position 1049 (L(1049N) or L(1049D)) by using dicistronic subgenomic replicons and found that the alteration of amino acid 1049 specifically affected transcriptional termination but had no effect on genome replication. L(1049N) recognized and terminated transcription at each of the naturally occurring gene junctions with differing efficiencies but at significantly higher efficiency than L(1049D). The abilities of the polymerases to recognize the cis-acting gene end signals required for termination were compared by examining the effect of single nucleotide changes at positions 1 to 8 of the M gene end and were found to be similar. This work identifies a single amino acid position in the polymerase that specifically affects the ability of the polymerase to terminate transcription, but which does not affect genome replication or interaction with the M2-1 protein. This work shows the critical importance of the previously defined cis-acting signals for termination, confirms differential termination at the varied gene junctions, and shows that the polymerase responds to the cis-acting sequences similarly, whether it has N or D at position 1049.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805433      PMCID: PMC164798          DOI: 10.1128/jvi.77.13.7352-7360.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  The versatility of paramyxovirus RNA polymerase stuttering.

Authors:  S Hausmann; D Garcin; C Delenda; D Kolakofsky
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Mutations in conserved domain II of the large (L) subunit of the Sendai virus RNA polymerase abolish RNA synthesis.

Authors:  S Smallwood; C D Easson; J A Feller; S M Horikami; S A Moyer
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

3.  The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination.

Authors:  K Juhasz; B R Murphy; P L Collins
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Mutations in domain V of the Sendai virus L polymerase protein uncouple transcription and replication and differentially affect replication in vitro and in vivo.

Authors:  C K Cortese; J A Feller; S A Moyer
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

5.  Spacing constraints on reinitiation of paramyxovirus transcription: the gene end U tract acts as a spacer to separate gene end from gene start sites.

Authors:  J C Rassa; G M Wilson; G A Brewer; G D Parks
Journal:  Virology       Date:  2000-09-01       Impact factor: 3.616

6.  Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  The Cys(3)-His(1) motif of the respiratory syncytial virus M2-1 protein is essential for protein function.

Authors:  R W Hardy; G W Wertz
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Mutations in conserved domains IV and VI of the large (L) subunit of the sendai virus RNA polymerase give a spectrum of defective RNA synthesis phenotypes.

Authors:  J A Feller; S Smallwood; S M Horikami; S A Moyer
Journal:  Virology       Date:  2000-04-10       Impact factor: 3.616

9.  The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription.

Authors:  R W Hardy; G W Wertz
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination.

Authors:  R W Hardy; S B Harmon; G W Wertz
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  15 in total

Review 1.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

Review 2.  What Really Rigs Up RIG-I?

Authors:  Sailen Barik
Journal:  J Innate Immun       Date:  2016-07-21       Impact factor: 7.349

Review 3.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection.

Authors:  Lan Chen; Weifeng Song; Ian C Davis; Kedar Shrestha; Erik Schwiebert; Wayne M Sullender; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-23       Impact factor: 6.914

5.  Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior.

Authors:  Kristina Brauburger; Yannik Boehmann; Verena Krähling; Elke Mühlberger
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

6.  Sequence-function analysis of the Sendai virus L protein domain VI.

Authors:  Andrea M Murphy; Megan Moerdyk-Schauwecker; Arcady Mushegian; Valery Z Grdzelishvili
Journal:  Virology       Date:  2010-07-06       Impact factor: 3.616

7.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase.

Authors:  Weifeng Song; Gang Liu; Charles A Bosworth; John R Walker; George A Megaw; Ahmed Lazrak; Edward Abraham; Wayne M Sullender; Sadis Matalon
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

9.  Factors affecting de novo RNA synthesis and back-priming by the respiratory syncytial virus polymerase.

Authors:  Sarah L Noton; Waleed Aljabr; Julian A Hiscox; David A Matthews; Rachel Fearns
Journal:  Virology       Date:  2014-07-08       Impact factor: 3.616

10.  A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.

Authors:  Stacey Human; Anne L Hotard; Larry J Anderson; Tina V Hartert; Martin L Moore; Christina A Rostad; Sujin Lee; Louise McCormick; Emma K Larkin; Teresa C T Peret; Jaume Jorba; Joseph Lanzone; Tebeb Gebretsadik; John V Williams; Melissa Bloodworth; Matthew Stier; Kecia Carroll; R Stokes Peebles
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.